Mounjaro or also known by its active ingredient, tirzepatide, which makes this drug works. This drug can be used for the treatment of type 2 diseases.
Mounjaro is an injection based drug which is given under skin to control type 2 diabetes.
Mounjaro has been approved by FDA, U.S. Food and Drug Administration saying Mounjaro (tirzepatide) injection improves blood sugar control levels in adults with type 2 diabetes, with an addition to diet and exercise.
Type 2 diabetes causes high blood sugar which may results in raising the risk of many conditions such as heart attack, kidney problems, vision or nerve conditions.
Mounjaro or Tirzepatide treats type 2 diabetes by lowering blood sugar level. It helps body to release more insulin, slowing the production of sugar in liver.
Mounjaro also helps in keeping you feel fuller for a longer period as it slows down emptying of food from stomach. Due to this, Mounjaro can also helps in weight loss.
Frequently Asked Questions about Mounjaro
Mounjaro also known as tirzepatide, an active ingredient for treating Type 2 disease.
Mounjaro is a prescription medication approved by the FDA to treat Type 2 diabetes.
Tirzepatide is a novel medication that is FDA approved for the treatment of type 2 diabetes mellitus. Given its potent weight loss properties, tirzepatide be used off-label for obesity treatment.
Mounjaro helps in maintaining blood sugar and also help in weight loss. So considering a diet which can be helpful with mounjaro medication should be considered. Here are a list of foods to eat on mounjaro and what food to be avoided.
Who makes Mounjaro ?
Mounjaro™ , which is a compound medicine of active ingredient named tirzepatide, are trademark owned by Eli Lilly and Company, its subsidiaries, or affiliates.
Mounjaro™ and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Along with Mounjaro, company also owns other devices. The company is about 140 years and has built their reputation and trust among its users.